EX-10.28 3 dex1028.htm CO-COMMERCIALIZATION AGREEMENT [*] indicates that a confidential portion of the text of this agreement has been omitted. The non- public information has been filed separately with the Securities and Exchange Commission....Co-Development and Co-Commercialization Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis Co-Development and Co-Commercialization Agreement, dated as of December 17, 2003 (the “Effective Date”), is between XOMA (US) LLC, a Delaware limited liability company (“XOMA”), located at 2910 Seventh Street, Berkeley, CA 94710, and ALEXION PHARMACEUTICALS, INC., a Delaware corporation (“Alexion”), located at 352 Knotter Drive, Cheshire, CT 06410.
CO-DEVELOPMENT AND CO-COMMERCIALIZATION AGREEMENTCo-Development and Co-Commercialization Agreement • March 22nd, 2004 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 22nd, 2004 Company Industry JurisdictionThis Co-Development and Co-Commercialization Agreement, dated as of December 17, 2003 (the “Effective Date”), is between XOMA (US) LLC, a Delaware limited liability company (“XOMA”), located at 2910 Seventh Street, Berkeley, CA 94710, and ALEXION PHARMACEUTICALS, INC., a Delaware corporation (“Alexion”), located at 352 Knotter Drive, Cheshire, CT 06410.